Kobayashi Pharmaceutical Co Ltd 2021 Integrated Report
Company: Kobayashi Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2021
Type: Integrated Report
Pages: 76
The report presents Kobayashi Pharmaceutical's 2021 consolidated performance, including net sales of ¥155.2 billion and coverage of the company and its consolidated subsidiaries. It describes a dedicated ESG function, a materiality-identification process, and 2030 Group emissions targets of 51% for Scope 1 and 2 and 15% for Scope 3 against 2018. The company reports TCFD-aligned climate analysis and 2021 CDP scores of B- for climate change and B for water security. Environmental highlights include 253,854 t of water resource consumption and 2,371 t of waste generated.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.